Download the app
App StorePlay Store
Beige
Login
← All tags

brokerages

Brokerages turn bullish on Meesho and Swiggy with calls offering up to 48% upside

Brokerages turn bullish on Meesho and Swiggy with calls offering up to 48% upside

Brokerages have started coverage on Meesho, Swiggy, and three other Indian stocks, spotlighting big upside potential. JP Morgan rates Meesho “Overweight” with about 11% upside, while Equirus gives Swiggy a “Buy” targeting roughly 48% gains. Analysts also turned constructive on Capillary Technologies, Shadowfax Technologies, and Shyam Metallics.

Summarised by Beize from a story on The Economic Times on 13 May 2026
Shree Cement shares surge 4% as Q4 profit slips 8% yet brokerages stay bullish

Shree Cement shares surge 4% as Q4 profit slips 8% yet brokerages stay bullish

Shree Cement shares jumped about 4% even after Q4 FY26 net profit fell 8% to Rs 526 crore. Revenue rose 10% to Rs 6,1010 crore, supported by strong sales volume growth both year-on-year and quarter-on-quarter. Brokerages like Nomura and Elara stayed optimistic, pointing to volume momentum and dividend payouts despite the profit dip.

Summarised by Beize from a story on The Economic Times on 7 May 2026

Your news, in seconds

App StorePlay Store
PNB shares surge 4 percent after Q4 profit jump while brokerages slash targets

PNB shares surge 4 percent after Q4 profit jump while brokerages slash targets

Punjab National Bank shares jumped about 4% after its Q4 FY26 net profit rose 14% and the bank declared a Rs 3 per equity dividend. Brokerages largely kept “Buy” calls, but several adjusted—often reduced—target prices, signaling caution over what the next earnings run could look like despite the strong quarter.

Summarised by Beize from a story on The Economic Times on 6 May 2026
Adani Energy Solutions rockets 63% in three months but brokerages stay wary

Adani Energy Solutions rockets 63% in three months but brokerages stay wary

Adani Energy Solutions has surged about 63% in three months as summer demand sparked fresh investor interest, making it the group’s second-best performer behind Adani Power. But despite the momentum, brokerages remain cautious. The jump appears closely tied to seasonality, raising questions about how sustainable the gains—and the outlook—really are.

Summarised by Beize from a story on The Economic Times on 29 Apr 2026
Broker calls go mixed as Motilal stays bullish on UTI AMC while Goldman cuts Dr Reddy’s

Broker calls go mixed as Motilal stays bullish on UTI AMC while Goldman cuts Dr Reddy’s

Brokerages are taking a selective approach in markets: Motilal Oswal has maintained a buy view on UTI AMC, citing steady AUM growth and healthy SIP inflows, as well as a bullish stance on Aditya Birla Sun Life AMC. In contrast, Goldman Sachs downgraded Dr Reddy’s Laboratories, pointing to weak pipeline visibility, pricing pressure, and limited near-term growth.

Summarised by Beize from a story on The Economic Times on 25 Apr 2026
Infosys shares slide after Q4 despite profit jump as FY27 growth outlook disappoints analysts

Infosys shares slide after Q4 despite profit jump as FY27 growth outlook disappoints analysts

Infosys shares fell after reporting a 21% rise in profit, as its FY27 revenue growth forecast of just 1.5% to 3.5% landed below expectations. Investors were also rattled by concerns over headcount reduction and fewer new deals. While brokerages remain split between Hold and Buy calls, most have cut price targets, citing macro uncertainty and AI disruption risk.

Summarised by Beize from a story on The Economic Times on 24 Apr 2026

Never miss a story

App StorePlay Store
Page 1

The full experience is on mobile.

Swipe through stories, personalise your feed, and save articles for later — all on the app.

Download on the App StoreGet it on Google Play